Showing all 2 results
Alfuzosin Hydrochloride Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended, Extended-Release (ER) Tablet, packed in high-barrier Alu-Alu blister strips to ensure API stability.
Active Ingredient Strength Primary Clinical Function Alfuzosin Hydrochloride USP/BP 10 mg The Standard Therapeutic Anchor: The globally validated once-daily dose for moderate-to-severe BPH symptoms. Excipients Extended-Release Matrix Controlled-Delivery System: Engineered to provide synchronized 24-hour therapeutic coverage, eliminating the need for multiple daily doses. Silodosin Tablets
FreeProduct Composition & Strength
We supply this product as a Precision-Blended Film-Coated Tablet, packed exclusively in highly secure, moisture-resistant Alu-Alu blister strips to ensure the absolute chemical stability of the active pharmaceutical ingredient.
Active Ingredient Strength Primary Clinical Function Silodosin INN/Ph.Eur. 8 mg Global Clinical Standard: Maximum adult daily dose for the rapid relief of lower urinary tract symptoms (LUTS) associated with BPH. Excipients Mannitol / Pregelatinized Starch / Sodium Stearyl Fumarate / Hypromellose / Titanium Dioxide Diluent / Binder / Lubricant / Film-Coating (Engineered for highly synchronized gastric dissolution and optimal bioavailability) *Pack Sizes: 10×10 Alu-Alu Blisters (Optimized specifically for high-compliance 30-day urology dispensing regimens).
